These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacological management of obsessive-compulsive disorder: a review for clinicians. McDonough M; Kennedy N Harv Rev Psychiatry; 2002; 10(3):127-37. PubMed ID: 12023928 [TBL] [Abstract][Full Text] [Related]
23. Obsessive-Compulsive Disorder: Advances in Diagnosis and Treatment. Hirschtritt ME; Bloch MH; Mathews CA JAMA; 2017 Apr; 317(13):1358-1367. PubMed ID: 28384832 [TBL] [Abstract][Full Text] [Related]
24. [Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art]. Kordon A; Zurowski B; Wahl K; Hohagen F Nervenarzt; 2011 Mar; 82(3):319-20, 322-4. PubMed ID: 21340636 [TBL] [Abstract][Full Text] [Related]
25. Treatment of pediatric obsessive-compulsive disorder: a review. Mancuso E; Faro A; Joshi G; Geller DA J Child Adolesc Psychopharmacol; 2010 Aug; 20(4):299-308. PubMed ID: 20807068 [TBL] [Abstract][Full Text] [Related]
26. Standard individual cognitive behaviour therapy for paediatric obsessive-compulsive disorder: a systematic review of effect estimates across comparisons. Skarphedinsson G; Hanssen-Bauer K; Kornør H; Heiervang ER; Landrø NI; Axelsdottir B; Biedilæ S; Ivarsson T Nord J Psychiatry; 2015 Feb; 69(2):81-92. PubMed ID: 25142430 [TBL] [Abstract][Full Text] [Related]
27. Side-effects of SSRIs disrupt multimodal treatment for pediatric OCD in a randomized-controlled trial. Reid AM; McNamara JP; Murphy TK; Guzick AG; Storch EA; Goodman WK; Geffken GR; Bussing R J Psychiatr Res; 2015 Dec; 71():140-7. PubMed ID: 26495770 [TBL] [Abstract][Full Text] [Related]
28. Systematic Review and Meta-Analysis: Cognitive-Behavioral Therapy for Obsessive-Compulsive Disorder in Children and Adolescents. Uhre CF; Uhre VF; Lønfeldt NN; Pretzmann L; Vangkilde S; Plessen KJ; Gluud C; Jakobsen JC; Pagsberg AK J Am Acad Child Adolesc Psychiatry; 2020 Jan; 59(1):64-77. PubMed ID: 31589909 [TBL] [Abstract][Full Text] [Related]
29. Cognitive behavioral and pharmacological treatments of OCD in children: A systematic review and meta-analysis. Öst LG; Riise EN; Wergeland GJ; Hansen B; Kvale G J Anxiety Disord; 2016 Oct; 43():58-69. PubMed ID: 27632568 [TBL] [Abstract][Full Text] [Related]
34. Tic-related obsessive-compulsive disorder (OCD): phenomenology and treatment outcome in the Pediatric OCD Treatment Study II. Conelea CA; Walther MR; Freeman JB; Garcia AM; Sapyta J; Khanna M; Franklin M J Am Acad Child Adolesc Psychiatry; 2014 Dec; 53(12):1308-16. PubMed ID: 25457929 [TBL] [Abstract][Full Text] [Related]
35. The place of and evidence for serotonin reuptake inhibitors (SRIs) for obsessive compulsive disorder (OCD) in children and adolescents: Views based on a systematic review and meta-analysis. Ivarsson T; Skarphedinsson G; Kornør H; Axelsdottir B; Biedilæ S; Heyman I; Asbahr F; Thomsen PH; Fineberg N; March J; Psychiatry Res; 2015 May; 227(1):93-103. PubMed ID: 25769521 [TBL] [Abstract][Full Text] [Related]
36. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials. Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912 [TBL] [Abstract][Full Text] [Related]
37. Mindfulness-based cognitive therapy in obsessive-compulsive disorder: protocol of a randomized controlled trial. Külz AK; Landmann S; Cludius B; Hottenrott B; Rose N; Heidenreich T; Hertenstein E; Voderholzer U; Moritz S BMC Psychiatry; 2014 Nov; 14():314. PubMed ID: 25403813 [TBL] [Abstract][Full Text] [Related]
38. A systematic review of the clinical effectiveness and cost-effectiveness of pharmacological and psychological interventions for the management of obsessive-compulsive disorder in children/adolescents and adults. Skapinakis P; Caldwell D; Hollingworth W; Bryden P; Fineberg N; Salkovskis P; Welton N; Baxter H; Kessler D; Churchill R; Lewis G Health Technol Assess; 2016 Jun; 20(43):1-392. PubMed ID: 27306503 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of 5-hydroxytryptamine-3 (5-HT3) receptor antagonists in augmentation with selective serotonin reuptake inhibitors (SSRIs) in the treatment of moderate to severe obsessive-compulsive disorder: a systematic review and meta-analysis of randomized clinical trials. Eissazade N; Mosavari H; Eghdami S; Boroon M; Ashrafi F; Shalbafan M Sci Rep; 2023 Nov; 13(1):20837. PubMed ID: 38012263 [TBL] [Abstract][Full Text] [Related]
40. Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). Garcia AM; Sapyta JJ; Moore PS; Freeman JB; Franklin ME; March JS; Foa EB J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1024-33; quiz 1086. PubMed ID: 20855047 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]